Suvorexant Completed Phase 1 Trials for Sleeplessness Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01293006Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032)
NCT01059851Pharmacokinetics of Suvorexant in Participants With Impaired Renal Function (MK-4305-023)(COMPLETED)
NCT01311882A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)